A Study to Evaluate the Maintenance of Efficacy and Long-term Safety of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)

Clinical trial NCT07733947 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07733947
Sponsor: Caliway Biopharmaceuticals Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Subcutaneous Fat

Start date: 2026-12-01
Primary completion: 2028-08-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.